Select acquires remainder of subsidiaries

By Melissa Trudinger
Tuesday, 30 November, 2004

Select Vaccines (ASX: SLT) will acquire the remaining 35 per cent of its two subsidiaries Picoral and Hepgenics from the Burnet Institute.

The institute will be issued 4 million new shares plus 2 million options in Select Vaccines in return for its equity.

Ongoing R&D programs being conducted by the Burnet Institute for the two companies will continue to be funded through December 2005.

More than a dozen bacterial species that live in people's mouths have been linked to a...

Life expectancy at birth in the world's longest-living populations has increased by an...

New research conducted in organoids is expected to provide pregnant women with epilepsy safer...

Content from other channels on our network

Scooping Up Success: Sajani Cups and Cones Freezes Out Stock Issues with Fishbowl

Managing Food Safety Risk Efficiently with Data Automation

Introducing Tool-Free Mounting and Reduced Service Times with Bürkert's Direct Acting Service Valves

Hygiene-first cables and connectors for the food and beverage industry

Futurecasting Food Science with data

Seamless modular I/O integration

Coca-Cola invests nearly $100 million in Queensland manufacturing

Endress+Hauser receives IEC 62443‍-‍4‍-‍1 cybersecurity certification

NSW announces TAFE Centre of Excellence in the Hunter

CSP to power pet food manufacturing in Wodonga

Medline introduces Namic Ready Set Kits

Solventum innovations enabling better, smarter, safer healthcare

Lumia Care expands national network with SA acquisition

Funding to support cervical cancer screening and treatment in the Pacific

Packaged foods: strict salt targets could prevent 40K cardiovascular events